Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The global Percutaneous Endoscopic Gastrostomy (PEG) Tube market was valued at USD 665 million in 2024 and is expected to reach USD 1.02 billion by 2031, exhibiting a CAGR of 6.2% during the forecast period. This growth is primarily driven by the increasing prevalence of chronic diseases requiring long-term nutritional support, advancements in minimally invasive surgical techniques, and growing geriatric populations globally.
A percutaneous endoscopic gastrostomy (PEG) tube is a flexible feeding tube inserted through the abdominal wall into the stomach, allowing for direct enteral nutrition in patients unable to maintain adequate oral intake. This procedure is commonly indicated for patients with neurological disorders, head and neck cancers, and other conditions causing dysphagia. The global market encompasses various product types including standard PEG tubes, low-profile gastrostomy tubes (button devices), and jejunal extension tubes, with the low-profile segment accounting for over 50% market share due to improved patient comfort and reduced complication rates.
Geographically, North America holds the largest market share at approximately 35%, followed by Asia-Pacific at 30%, which is attributed to higher procedure volumes, well-established healthcare infrastructure, and favorable reimbursement policies in developed markets. The Asia-Pacific region shows the highest growth rate due to increasing healthcare expenditure and rising awareness about enteral nutrition options.
Key industry participants include Fresenius Kabi AG, Cardinal Health Inc., and Nestlé Health Science, collectively holding about 40% market share. Other significant players include Avanos Medical, Danone, Applied Medical Technology, Boston Scientific, Cook Group, ConMed, and GBUK Group. These companies focus on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.
The market faces challenges including stringent regulatory requirements for medical devices, high procedure costs in developing regions, and the need for specialized training for healthcare providers. However, increasing adoption of home-based care and technological advancements in tube design continue to drive market growth.
Rising Prevalence of Chronic Illnesses Requiring Long-Term Nutritional Support
The increasing incidence of neurological disorders, head and neck cancers, and gastrointestinal disorders that impair swallowing function is a primary driver for PEG tube market growth. Conditions like stroke, ALS, and Parkinson's disease create sustained demand for enteral feeding solutions.
Advancements in Endoscopic Technologies and Techniques
Innovations in endoscopic equipment and procedural techniques have made PEG tube placement safer, faster, and more efficient. Improved visualization systems and specialized delivery devices enable physicians to perform procedures with higher success rates and fewer complications.
➤ Growing geriatric population significantly contributes to market expansion as elderly patients more frequently require long-term enteral nutrition support due to age-related conditions and complex comorbidities
The shift toward minimally invasive procedures across healthcare systems globally continues to drive adoption of PEG tube placement over more invasive surgical alternatives.
MARKET CHALLENGES
High Procedure Costs and Reimbursement Limitations
PEG tube procedures involve significant costs including endoscopic equipment, specialized tubes, and professional fees. In many healthcare systems, reimbursement rates don't fully cover these expenses, creating financial constraints for both providers and patients. Some insurance providers consider certain PEG tube placements as elective rather than essential procedures.
Other Challenges
Technical Complexity and Training Requirements
Proper PEG tube placement requires specialized gastroenterological training that isn't universally available. Smaller healthcare facilities and rural areas face challenges in accessing specialists with sufficient experience, leading to geographic disparities in care quality.
Risk of Procedure-Related Complications
Despite technological advancements, PEG tube placement carries risks including infection, bleeding, and peritonitis. These complications, occurring in approximately 5-10% of cases, create hesitancy among both patients and physicians, particularly for borderline cases where oral nutrition might still be possible with careful management.
Expansion into Emerging Markets with Growing Healthcare Infrastructure
Developing regions with improving healthcare infrastructure present significant growth opportunities. As endoscopic equipment becomes more accessible and training programs expand, previously underserved populations gain access to PEG tube procedures. The Asia-Pacific region shows particularly strong growth potential with expanding medical coverage and aging populations driving demand.
Advancements in Tube Design and Material Technology
Next-generation PEG tubes with enhanced materials reduce complications and improve patient outcomes. Antimicrobial coatings, improved flexibility, and reduced foreign body response contribute to market growth. Manufacturers developing specialized tubes for specific patient populations (pediatric vs. geriatric) create new market segments and application areas.
Integration with Telemedicine and Remote Monitoring
The rise of telemedicine enables remote monitoring of PEG tube patients, reducing complications and hospital readmissions. Integration with digital health platforms creates opportunities for post-procedure care optimization and creates additional revenue streams beyond the initial procedure itself.
| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Low-Profile PEG Tubes are gaining significant traction due to their enhanced patient comfort and discreet appearance under clothing, while maintaining full functionality. Their integrated design reduces external tube length, minimizing discomfort and improving quality of life for long-term enteral nutrition patients. |
| By Application |
|
Enteral Nutrition Delivery remains the primary application, driven by the growing prevalence of chronic conditions requiring long-term nutritional support. The segment demonstrates consistent innovation in tube design to optimize flow rates and minimize complications, with manufacturers focusing on anti-clogging features and compatibility with various nutritional formulations. |
| By End User |
|
Hospitals & Surgical Centers represent the primary end-users, given that PEG tube placement is predominantly a surgical procedure performed in hospital settings. The segment drives innovation in procedural techniques and post-operative care protocols, with increasing emphasis on training programs for gastroenterologists and surgical teams to enhance placement precision and reduce complication rates. |
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
Cook Medical leads the PEG tube market with its extensive portfolio of endoscopic enteral access devices, holding significant market share through its global distribution network and focus on procedural safety innovations.
Boston Scientific and Medtronic follow closely, competing through technological innovations in tube materials and insertion techniques, particularly with their anti-reflux valve technologies and low-profile gastrostomy devices.
ConMed Corporation is expanding through strategic acquisitions, recently acquiring a smaller endoscopy company to enhance its gastrointestinal product line and strengthen its position in the PEG tube accessories market.
Fujifilm Holdings and Olympus Corporation are leveraging their endoscopic imaging expertise to develop integrated PEG solutions, combining visualization technologies with tube placement systems for improved procedural outcomes.
List of Key PEG Tube Companies ProfiledCook Medical (United States)
Boston Scientific Corporation (United States)
Medtronic plc (Ireland)
ConMed Corporation (United States)
Olympus Corporation (Japan)
Fujifilm Holdings (Japan)
The global PEG tube market is experiencing significant growth due to the increasing geriatric population worldwide, who are more susceptible to conditions requiring enteral nutrition support. Market analysis indicates a compound annual growth rate of 6.8% across major healthcare markets, with particular strength in North America and Europe where over 65% of procedures are performed on patients aged 65 and above. This demographic shift is creating sustained demand for both the initial placement procedures and the ongoing maintenance and replacement market segments.
Other TrendsTechnological Advancements in Tube Design
Recent innovations in PEG tube technology include the development of low-profile gastrostomy tubes that offer improved patient comfort and reduced skin irritation. The market has seen a 40% increase in adoption of these advanced devices over the past three years, particularly in outpatient and homecare settings. Manufacturers are focusing on materials that reduce biofilm formation, with studies showing a 35% decrease in tube-related infections with newer polymer compositions. The integration of antimicrobial coatings has become standard in premium product lines, contributing to better long-term patient outcomes and reduced healthcare costs.
The shift toward home-based care continues to influence the PEG tube market, with 68% of patients now receiving their nutrition support in home settings rather than institutional care facilities. This trend has driven demand for more user-friendly tube designs and comprehensive homecare training programs. The homecare segment now accounts for approximately 42% of the total market revenue, with projections indicating this will grow to 55% within the next five years. This shift is driving innovation in connection systems, drainage solutions, and mobile monitoring technologies that support home-based care teams.
Regional Analysis: Percutaneous Endoscopic Gastrostomy (PEG) Tube MarketEurope
Europe represents the second largest market for PEG tubes globally, with Germany, France, and the United Kingdom leading in utilization rates. The European market benefits from comprehensive healthcare coverage that includes enteral nutrition support as part of standard care pathways. Regulatory harmonization across the EU facilitates device approval and distribution. Eastern European markets show accelerating growth as healthcare systems modernize. The region maintains strong clinical evidence generation supporting appropriate use across diverse patient populations from pediatric to geriatric applications.
Asia-Pacific
Asia-Pacific demonstrates the fastest growth rate for PEG tube adoption, particularly in developed markets like Japan, South Korea, and Australia. Rising healthcare expenditure enables investment in endoscopic equipment and staff training. Cultural acceptance of long-term nutritional support drives market expansion beyond traditional hospital settings into home care. Regional manufacturing capabilities continue to improve with Japanese and Korean companies gaining international market share. The region benefits from aging populations requiring complex care management.
Latin America
Latin America shows steady growth in PEG tube utilization, particularly in Brazil, Mexico, and Argentina. Economic development allows for improved healthcare infrastructure including endoscopy suites and interventional radiology. Public health initiatives increasingly recognize the importance of nutritional support. Medical societies develop local guidelines adapted from international standards while addressing regional challenges including tropical diseases and varied nutritional status.
Middle East & Africa
The Middle East shows the strongest development in Gulf Cooperation Council countries with high-quality healthcare systems adopting PEG tubes as standard of care. Sub-Saharan Africa demonstrates initial growth through international health organization partnerships focusing on nutritional support in complex care. Regional training initiatives develop among gastroenterologists and interventional radiologists. The region shows the greatest potential for future growth as healthcare infrastructure develops.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2031. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Pharmaceutical and biotech companies
Medical device and diagnostics manufacturers
Healthcare providers and hospital systems
Contract research and manufacturing organizations
Investors, consultants, and policy makers
-> The Global Percutaneous Endoscopic Gastrostomy (PEG) Tube market was valued at USD 665 million in 2024 and is expected to reach USD 1002 million by 2031.
-> The market is projected to grow at a CAGR of 6.2% during the forecast period (2024-2031).
-> Fresenius Kabi, Cardinal Health and Nestle are the top 3 companies with about 40% market share.
-> Low profile G-tube segment holds over 50% market share followed by high profile G-tube.
-> Americas holds about 35% market share, followed by APAC with about 30% share.
-> Over 60% of PEG tubes are used for adult patients.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates